News

The wearable, transcutaneous neurostimulation device delivers personalized therapy using a proprietary AI algorithm.
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company ...
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
Moon Surgical today announced it received FDA 510(k) clearance for two new features on the Maestro robotic surgical assistant ...
The pulsed field ablation developer Kardium has collected $250 million in funding to gear up for the commercial expansion of ...
Fasikl announced that it received FDA 510(k) clearance for its first-of-its-kind NeuroAI wristband for essential tremor.
Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...
The FDA's breakthrough devices program helps the industry with faster review times, but the benefit to patients is unclear.
Takeda Pharmaceuticals said the Food and Drug Administration approved its liquid Gammagard immunoglobulin treatment. The drugmaker said Monday that commercialization of Gammagard Liquid is expected to ...